North America Clinical Nutrition Market 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity
North America Clinical Nutrition Market 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity
Insights into the North America Clinical Nutrition Market include supply chain optimization, North America Clinical Nutrition challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
North America clinical nutrition market is projected to grow by 7.6% annually in the forecast period and reach $27.64 billion by 2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births.
Highlighted with 61 tables and 74 figures, this 149-page report “North America Clinical Nutrition Market 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, Dosage Form, Therapeutic Area, End User, Healthcare Setting, Distribution Channel, and Country.
Based on Substrate, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Carbohydrates
• Lipids
• Proteins & Amino Acids
• Water & Electrolyte
• Dietary Fiber
• Antioxidants
• Other Substrates
Based on Administration Route, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Oral or Enteral Administration
o Oral Nutrition Supplements
o Tube Feeding
• Parenteral Administration
o Supplemental Parenteral Nutrition
o Total Parenteral Nutrition
o All-in-One System
o Multiple Bottle System
By Dosage Form, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Powder
• Liquid
• Solid and Semi-solid
By Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Malnutrition
• Metabolic Disorders
• Gastrointestinal Disorders
• Cancer
• Neurology
• Renal Diseases
• Respiratory Diseases
• Other Therapeutic Areas
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infant
• Children
• Adult
• Geriatrics
By Healthcare Setting, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Hospitals
• Long-term Care Facilities (LTC)
• Homecare
• Inpatient Rehabilitation Facilities
• Other Healthcare Settings
By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Institutional Sales
• Supermarkets & Hypermarkets
• Pharmacies
• Drug Stores
• Online Channels
• Other Distribution Channels
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Administration Route, Therapeutic Area, and End User over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Nutrition
B Braun Melsungen Ag
BASF SE
Baxter International Inc.
Claris Lifesciences Ltd.
Fresenius Kabi Ag
Lonza Group AG
Nestlé S.A.
Nutricia Ltd
Perrigo Company Plc
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter’s Fiver Forces Analysis 44
3 Segmentation of North America Market by Substrate 48
3.1 Market Overview by Substrate 48
3.2 Carbohydrates 50
3.3 Lipids 51
3.4 Proteins & Amino Acids 52
3.5 Water & Electrolyte 53
3.6 Dietary Fiber 54
3.7 Antioxidants 55
3.8 Other Substrates 56
4 Segmentation of North America Market by Administration Route 57
4.1 Market Overview by Administration Route 57
4.2 Oral or Enteral Administration 59
4.2.1 Oral Nutrition Supplements 60
4.2.2 Tube Feeding 61
4.3 Parenteral Administration 62
4.3.1 Supplemental Parenteral Nutrition 64
4.3.2 Total Parenteral Nutrition 65
4.3.3 All-in-One System 66
4.3.4 Multiple Bottle System 67
5 Segmentation of North America Market by Dosage Form 68
5.1 Market Overview by Dosage Form 68
5.2 Powder 70
5.3 Liquid 71
5.4 Solid and Semi-solid 72
6 Segmentation of North America Market by Therapeutic Area 73
6.1 Market Overview by Therapeutic Area 73
6.2 Malnutrition 75
6.3 Metabolic Disorders 76
6.4 Gastrointestinal Disorders 77
6.5 Cancer 78
6.6 Neurology 79
6.7 Renal Diseases 80
6.8 Respiratory Diseases 81
6.9 Other Therapeutic Areas 82
7 Segmentation of North America Market by End User 83
7.1 Market Overview by End User 83
7.2 Infant 85
7.3 Children 86
7.4 Adult 87
7.5 Geriatrics 88
8 Segmentation of North America Market by Healthcare Setting 89
8.1 Market Overview by Healthcare Setting 89
8.2 Hospitals 91
8.3 Long-term Care Facilities (LTC) 92
8.4 Homecare 93
8.5 Inpatient Rehabilitation Facilities 94
8.6 Other Healthcare Settings 95
9 Segmentation of North America Market by Distribution Channel 96
9.1 Market Overview by Distribution Channel 96
9.2 Institutional Sales 98
9.3 Supermarkets & Hypermarkets 99
9.4 Pharmacies 100
9.5 Drug Stores 101
9.6 Online Channels 102
9.7 Other Distribution Channels 103
10 North America Market 2022-2032 by Country 104
10.1 Overview of North America Market 104
10.2 U.S. 107
10.3 Canada 110
10.4 Mexico 112
11 Competitive Landscape 114
11.1 Overview of Key Vendors 114
11.2 New Product Launch, Partnership, Investment, and M&A 117
11.3 Company Profiles 118
Abbott Nutrition 118
B Braun Melsungen Ag 120
BASF SE 123
Baxter International Inc. 126
Claris Lifesciences Ltd. 129
Fresenius Kabi Ag 130
Lonza Group AG 133
Nestlé S.A. 137
Nutricia Ltd 142
Perrigo Company Plc 146
RELATED REPORTS 149
Tables & Figures:
List of Tables:
Table 1. Snapshot of North America Clinical Nutrition Market in Balanced Perspective, 2022-2032 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 28
Table 5. World Health Spending by Region, $ bn, 2013-2020 36
Table 6. Main Product Trends and Market Opportunities in North America Clinical Nutrition Market 40
Table 7. North America Clinical Nutrition Market by Substrate, 2022-2032, $ mn 48
Table 8. North America Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 57
Table 9. North America Clinical Nutrition Market: Oral or Enteral Administration by Type, 2022-2032, $ mn 59
Table 10. North America Clinical Nutrition Market: Parenteral Administration by Type, 2022-2032, $ mn 63
Table 11. North America Clinical Nutrition Market by Dosage Form, 2022-2032, $ mn 68
Table 12. North America Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 73
Table 13. North America Clinical Nutrition Market by End User, 2022-2032, $ mn 83
Table 14. North America Clinical Nutrition Market by Healthcare Setting, 2022-2032, $ mn 89
Table 15. North America Clinical Nutrition Market by Distribution Channel, 2022-2032, $ mn 96
Table 16. North America Clinical Nutrition Market by Country, 2022-2032, $ mn 105
Table 17. U.S. Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 109
Table 18. U.S. Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 109
Table 19. U.S. Clinical Nutrition Market by End User, 2022-2032, $ mn 109
Table 20. Canada Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 111
Table 21. Canada Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 111
Table 22. Canada Clinical Nutrition Market by End User, 2022-2032, $ mn 111
Table 23. Mexico Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 113
Table 24. Mexico Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 113
Table 25. Mexico Clinical Nutrition Market by End User, 2022-2032, $ mn 113
Table 26. Abbott Nutrition: Company Snapshot 118
Table 27. Abbott Nutrition: Business Segmentation 119
Table 28. Abbott Nutrition: Product Portfolio 119
Table 29. B Braun Melsungen Ag: Company Snapshot 120
Table 30. B Braun Melsungen Ag: Business Segmentation 121
Table 31. B Braun Melsungen Ag: Revenue by Region 121
Table 32. B Braun Melsungen Ag: Product Portfolio 122
Table 33. BASF: Company Snapshot 123
Table 34. BASF: Business Segmentation 124
Table 35. BASF: Revenue by Region 124
Table 36. BASF: Product Portfolio 125
Table 37. Baxter International Inc.: Company Snapshot 126
Table 38. Baxter International Inc.: Business Segmentation 126
Table 39. Baxter International Inc.: Revenue by Region 127
Table 40. Baxter International Inc.: Product Portfolio 127
Table 41. Claris Lifesciences Ltd.: Company Snapshot 129
Table 42. Fresenius Kabi Ag: Company Snapshot 130
Table 43. Fresenius Kabi Ag: Business Segmentation 131
Table 44. Fresenius Kabi Ag: Revenue by Region 131
Table 45. Fresenius Kabi Ag: Product Portfolio 132
Table 46. Lonza Group: Company Snapshot 133
Table 47. Lonza Group: Business Segmentation in 2018 134
Table 48. Lonza Group: Product Portfolio 134
Table 49. Lonza Group: Revenue by Region in 2018 135
Table 50. Nestlé S.A.: Company Snapshot 137
Table 51. Nestlé S.A.: Business Segmentation 137
Table 52. Nestlé S.A.: Product Portfolio 138
Table 53. Nestlé S.A.: Revenue, 2018-2020, $ bn 140
Table 54. Nutricia Ltd: Company Snapshot 142
Table 55. Nutricia Ltd: Business Segmentation 143
Table 56. Nutricia Ltd: Revenue by Region 143
Table 57. Nutricia Ltd: Product Portfolio 144
Table 58. Perrigo Company Plc: Company Snapshot 146
Table 59. Perrigo Company Plc: Business Segmentation 147
Table 60. Perrigo Company Plc: Revenue by Region 147
Table 61. Perrigo Company Plc: Product Portfolio 147
List of Figures:
Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 18
Figure 4. North America Clinical Nutrition Market, 2022-2032, $ mn 21
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of North America Clinical Nutrition Market 31
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 34
Figure 8. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 35
Figure 9. Forecast of World Middle-class Population by Region, 2015-2030, million 35
Figure 10. Primary Restraints and Impact Factors of North America Clinical Nutrition Market 37
Figure 11. Investment Opportunity Analysis 41
Figure 12. Porter’s Fiver Forces Analysis of North America Clinical Nutrition Market 44
Figure 13. Breakdown of North America Clinical Nutrition Market by Substrate, 2022-2032, % of Revenue 49
Figure 14. North America Addressable Market Cap in 2023-2032 by Substrate, Value ($ mn) and Share (%) 49
Figure 15. North America Clinical Nutrition Market by Substrate: Carbohydrates, 2022-2032, $ mn 50
Figure 16. North America Clinical Nutrition Market by Substrate: Lipids, 2022-2032, $ mn 51
Figure 17. North America Clinical Nutrition Market by Substrate: Proteins & Amino Acids, 2022-2032, $ mn 52
Figure 18. North America Clinical Nutrition Market by Substrate: Water & Electrolyte, 2022-2032, $ mn 53
Figure 19. North America Clinical Nutrition Market by Substrate: Dietary Fiber, 2022-2032, $ mn 54
Figure 20. North America Clinical Nutrition Market by Substrate: Antioxidants, 2022-2032, $ mn 55
Figure 21. North America Clinical Nutrition Market by Substrate: Other Substrates, 2022-2032, $ mn 56
Figure 22. Breakdown of North America Clinical Nutrition Market by Administration Route, 2022-2032, % of Sales Revenue 58
Figure 23. North America Addressable Market Cap in 2023-2032 by Administration Route, Value ($ mn) and Share (%) 58
Figure 24. North America Clinical Nutrition Market by Administration Route: Oral or Enteral Administration, 2022-2032, $ mn 59
Figure 25. North America Clinical Nutrition Market by Oral or Enteral Administration: Oral Nutrition Supplements, 2022-2032, $ mn 60
Figure 26. North America Clinical Nutrition Market by Oral or Enteral Administration: Tube Feeding, 2022-2032, $ mn 61
Figure 27. North America Clinical Nutrition Market by Administration Route: Parenteral Administration, 2022-2032, $ mn 62
Figure 28. North America Clinical Nutrition Market by Parenteral Administration: Supplemental Parenteral Nutrition, 2022-2032, $ mn 64
Figure 29. North America Clinical Nutrition Market by Parenteral Administration: Total Parenteral Nutrition, 2022-2032, $ mn 65
Figure 30. North America Clinical Nutrition Market by Parenteral Administration: All-in-One System, 2022-2032, $ mn 66
Figure 31. North America Clinical Nutrition Market by Parenteral Administration: Multiple Bottle System, 2022-2032, $ mn 67
Figure 32. Breakdown of North America Clinical Nutrition Market by Dosage Form, 2022-2032, % of Sales Revenue 69
Figure 33. North America Addressable Market Cap in 2023-2032 by Dosage Form, Value ($ mn) and Share (%) 69
Figure 34. North America Clinical Nutrition Market by Dosage Form: Powder, 2022-2032, $ mn 70
Figure 35. North America Clinical Nutrition Market by Dosage Form: Liquid, 2022-2032, $ mn 71
Figure 36. North America Clinical Nutrition Market by Dosage Form: Solid and Semi-solid, 2022-2032, $ mn 72
Figure 37. Breakdown of North America Clinical Nutrition Market by Therapeutic Area, 2022-2032, % of Revenue 74
Figure 38. North America Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%) 74
Figure 39. North America Clinical Nutrition Market by Therapeutic Area: Malnutrition, 2022-2032, $ mn 75
Figure 40. North America Clinical Nutrition Market by Therapeutic Area: Metabolic Disorders, 2022-2032, $ mn 76
Figure 41. North America Clinical Nutrition Market by Therapeutic Area: Gastrointestinal Disorders, 2022-2032, $ mn 77
Figure 42. North America Clinical Nutrition Market by Therapeutic Area: Cancer, 2022-2032, $ mn 78
Figure 43. North America Clinical Nutrition Market by Therapeutic Area: Neurology, 2022-2032, $ mn 79
Figure 44. North America Clinical Nutrition Market by Therapeutic Area: Renal Diseases, 2022-2032, $ mn 80
Figure 45. North America Clinical Nutrition Market by Therapeutic Area: Respiratory Diseases, 2022-2032, $ mn 81
Figure 46. North America Clinical Nutrition Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn 82
Figure 47. Breakdown of North America Clinical Nutrition Market by End User, 2022-2032, % of Revenue 84
Figure 48. North America Addressable Market Cap in 2023-2032 by End User, Value ($ mn) and Share (%) 84
Figure 49. North America Clinical Nutrition Market by End User: Infant, 2022-2032, $ mn 85
Figure 50. North America Clinical Nutrition Market by End User: Children, 2022-2032, $ mn 86
Figure 51. North America Clinical Nutrition Market by End User: Adult, 2022-2032, $ mn 87
Figure 52. North America Clinical Nutrition Market by End User: Geriatrics, 2022-2032, $ mn 88
Figure 53. Breakdown of North America Clinical Nutrition Market by Healthcare Setting, 2022-2032, % of Revenue 89
Figure 54. North America Addressable Market Cap in 2023-2032 by Healthcare Setting, Value ($ mn) and Share (%) 90
Figure 55. North America Clinical Nutrition Market by Healthcare Setting: Hospitals, 2022-2032, $ mn 91
Figure 56. North America Clinical Nutrition Market by Healthcare Setting: Long-term Care Facilities (LTC), 2022-2032, $ mn 92
Figure 57. North America Clinical Nutrition Market by Healthcare Setting: Homecare, 2022-2032, $ mn 93
Figure 58. North America Clinical Nutrition Market by Healthcare Setting: Inpatient Rehabilitation Facilities, 2022-2032, $ mn 94
Figure 59. North America Clinical Nutrition Market by Healthcare Setting: Other Healthcare Settings, 2022-2032, $ mn 95
Figure 60. Breakdown of North America Clinical Nutrition Market by Distribution Channel, 2022-2032, % of Revenue 97
Figure 61. North America Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%) 97
Figure 62. North America Clinical Nutrition Market by Distribution Channel: Institutional Sales, 2022-2032, $ mn 98
Figure 63. North America Clinical Nutrition Market by Distribution Channel: Supermarkets & Hypermarkets, 2022-2032, $ mn 99
Figure 64. North America Clinical Nutrition Market by Distribution Channel: Pharmacies, 2022-2032, $ mn 100
Figure 65. North America Clinical Nutrition Market by Distribution Channel: Drug Stores, 2022-2032, $ mn 101
Figure 66. North America Clinical Nutrition Market by Distribution Channel: Online Channels, 2022-2032, $ mn 102
Figure 67. North America Clinical Nutrition Market by Distribution Channel: Other Distribution Channels, 2022-2032, $ mn 103
Figure 68. Breakdown of North America Clinical Nutrition Market by Country, 2022 and 2032, % of Revenue 105
Figure 69. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 106
Figure 70. U.S. Clinical Nutrition Market, 2022-2032, $ mn 108
Figure 71. Canada Clinical Nutrition Market, 2022-2032, $ mn 110
Figure 72. Clinical Nutrition Market in Mexico, 2022-2032, $ mn 112
Figure 73. Growth Stage of North America Clinical Nutrition Industry over the Forecast Period 114
Figure 74. Nestlé S.A.: Revenue by Region, 2018 140
Research Methodology:
North America Clinical Nutrition Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|